Klivira
Request demo

Navigating Rexulti Prior Authorization for Orthopedics: A Workflow Imperative

Managing Rexulti prior authorization for orthopedics patients presents unique operational challenges, requiring robust systems to ensure timely access to critical medications amidst complex care pathways.

Orthopedic practices frequently manage patients with comorbid conditions, including psychiatric diagnoses, necessitating a comprehensive approach to prior authorization. While Rexulti (brexpiprazole) is not an orthopedic drug, its status as a high-volume PA target across all payer types means orthopedic practices, especially within integrated health systems, must navigate its specific authorization requirements alongside their primary specialty-specific PAs. This dual burden demands an efficient, automated solution to prevent treatment delays and reduce administrative overhead.

Rexulti Prior Authorization in the Orthopedic Care Continuum

Patients undergoing orthopedic treatment, from joint replacement to spine surgery, often contend with co-occurring mental health conditions such as depression or anxiety. While atypical antipsychotics like Rexulti are prescribed by mental health specialists or PCPs, orthopedic practices operating within integrated systems frequently encounter these medication PAs. Successfully managing Rexulti prior authorization for orthopedics patients requires understanding its general PA criteria and integrating this into an already demanding orthopedic PA workflow.

Typical Prior Authorization Requirements for Medications like Rexulti

  • Documentation of diagnosis and severity of condition (e.g., MDD, schizophrenia).
  • History of failed trials with preferred first-line agents (step therapy adherence).
  • Clinical rationale for Rexulti's selection over other atypical antipsychotics.
  • Evidence of ongoing treatment and patient response to therapy.
  • Consideration of potential drug interactions with other prescribed medications.

Navigating High-Volume Orthopedic Prior Authorization Demands

Orthopedic practices face an inherently high volume of prior authorizations for procedures, imaging, and durable medical equipment. This includes major joint replacement, spine surgery, advanced imaging (MRI/CT), and sports medicine procedures. The complexity is further compounded by strict payer policies requiring extensive documentation of conservative care trials and adherence to guidelines such as the AAOS Clinical Practice Guidelines and ACR Appropriateness Criteria.

Common Orthopedic PA Denial Reasons to Mitigate

  • Insufficient documentation of conservative-care trial duration and modalities.
  • Failure to meet payer-specific BMI criteria for elective joint replacement.
  • Gaps in correlating imaging findings with documented patient symptoms.
  • Non-adherence to appropriateness criteria for advanced musculoskeletal imaging.
  • Requests for procedures or DME considered non-covered or requiring step therapy by payer policy.

Klivira's Solution for Integrated Rexulti and Orthopedic PA Management

Klivira's platform is engineered to manage the full spectrum of prior authorizations, from high-volume medications like Rexulti to complex orthopedic procedures. By integrating seamlessly with EMRs via SMART on FHIR, Klivira automates data extraction for both medication and procedural PAs, ensuring accurate and complete submissions. This comprehensive approach helps orthopedic practices streamline workflows, reduce administrative burden, and accelerate approvals for all patient care components.

Leveraging EMR Integration for Comprehensive PA Submissions

For medications like Rexulti, Klivira queries EMR data points such as diagnosis codes, medication history, and documented treatment trials. For orthopedic procedures, our system extracts critical information on conservative care, imaging results, and physical exam findings. This automated data retrieval minimizes manual entry errors and ensures that all required clinical documentation, whether for a psychiatric medication or a complex spine surgery, is accurately compiled and submitted via X12 278, ePA, or payer portals.

Frequently asked questions

Why would an orthopedic practice need to manage Rexulti prior authorizations?

Orthopedic patients often have comorbid mental health conditions, and while Rexulti is prescribed by other specialists, orthopedic practices within integrated health systems may be involved in coordinating all patient care PAs. Moreover, Rexulti is a high-volume PA drug across many plans, making efficient management crucial for overall patient flow and revenue cycle integrity.

What are the common challenges in obtaining prior authorization for Rexulti?

Challenges for medications like Rexulti typically involve demonstrating medical necessity, adherence to step therapy protocols, and documenting the efficacy of prior treatments. Payers often require specific clinical criteria to be met, including diagnostic confirmation and a clear rationale for selecting Rexulti over alternative therapies, especially for long-term use.

How does Klivira address the dual challenge of medication and orthopedic procedure PAs?

Klivira provides a unified platform that automates data extraction from EMRs for both medication and procedural PAs. For orthopedics, this includes conservative care trials and imaging. For medications like Rexulti, it covers diagnosis and treatment history. Our system orchestrates submission via various channels, including X12 278 and payer portals, streamlining the entire process.

Are there specific payer guidelines for Rexulti that impact orthopedic patients?

Payer guidelines for Rexulti are generally focused on its approved indications (e.g., schizophrenia, adjunctive MDD) and typical step therapy requirements, rather than specific orthopedic considerations. However, these guidelines apply to any patient, including those receiving orthopedic care. Understanding these requirements is essential to prevent delays in medication access that could indirectly impact orthopedic treatment.

How does Klivira help reduce denials for complex orthopedic cases with comorbidities?

Klivira leverages its AAOS-guideline-aware logic for orthopedic procedures, ensuring conservative care documentation is complete. For comorbid conditions requiring medications like Rexulti, it ensures all relevant clinical data is extracted. By automating documentation checks and routing submissions correctly, Klivira significantly reduces common denial reasons, including insufficient clinical information or failure to meet payer criteria for both drug and procedure PAs.

Related coverage

Other rexulti prior authorization by payer

Other rexulti prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo